Getting Smarter in How We Score and Promote Value
May
Getting On Pathway?
Signaling the Future of Personalized Medicine
Money Well Spent?
SABCS Conference Coverage
This article was sponsored by Eisai Inc. The 2012 Eisai Oncology Digest was commissioned and funded by Eisai Inc.
Multiple Myeloma: Pre-Transplant Induction, Consolidation, and Maintenance Therapy
Availability of Newer Agents May Lower Healthcare Costs
Interview With Allen S. Lichter, MD, Chief Executive Officer, American Society of Clinical Oncology
UPMC Oncologists: Pioneers in the Clinical Pathways Movement
Advertisement
Advertisement
Trending on AJMC
1
Promises and Pitfalls of AI in Health Care
2
SCRI’s Vivek Subbiah, MD, Highlights Trials on Tumor-Agnostic Cancer Therapies During ESMO
3
With New OUD Diagnoses on the Rise, More Comprehensive Screenings Needed
4
FDA Expands Sotatercept Indication for PAH
5
